Home › Prostate Cancer › NCT06067295
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * Men of all racial and ethnic groups 18 years of age or older * Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy) * Prior participation on clinical trials is allowed Exclusion Criteria: * Inability to give informed consent * Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
About the study
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
What is being tested
- Non-Interventional Study (other)
Sponsor: University of Southern California · Participants: 300 · Started: Feb 21, 2023
Contact the study team
- Cheryl Kefauver, RN · Phone: 323-865-0459
Official record on ClinicalTrials.gov — NCT06067295
Locations in the U.S.
| California | Los Angeles General Medical Center, Los Angeles USC / Norris Comprehensive Cancer Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.